Filing Details

Accession Number:
0001209191-12-018272
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-14 16:30:18
Reporting Period:
2012-03-13
Filing Date:
2012-03-14
Accepted Time:
2012-03-14 16:30:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1160308 Adventrx Pharmaceuticals Inc ANX Pharmaceutical Preparations (2834) 841318182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1310683 M Brian Culley 12390 El Camino Real, Suite 150
San Diego CA 92130
Ceo And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-13 14,000 $0.58 14,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions executed by a broker-dealer at prices ranging from $0.5750 to $0.5848, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.